As part of a report on incentivizing use of accountable care organizations (ACOs), Congress’ primary research arm recently recommended excluding [...] …
Category: Regulatory
Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The state agency tasked with implementing Maine’s state 340B hospital reporting requirement has proposed a rule with additional data and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators recently said any decision on whether to provide Medicare Advantage (MA) plans funds to reimburse hospitals for past [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
HRSA Issues Final Regulations Revamping Process to Resolve Disputes Between 340B Providers and Manufacturers
The federal government issued the final rule early Thursday to implement a long-anticipated revision to the 340B Administrative Dispute Resolution [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court panel pressed both the AIDS Healthcare Foundation and (AHF) and Apexus, the 340B prime vendor, to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare paid hospitals substantially more—almost $4 billion in aggregate—than the 340B ceiling price costs for dozens of single-source drugs, biologics [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...] …
